Literature DB >> 2889144

Germline mosaicism and Duchenne muscular dystrophy mutations.

E Bakker1, C Van Broeckhoven, E J Bonten, M J van de Vooren, H Veenema, W Van Hul, G J Van Ommen, A Vandenberghe, P L Pearson.   

Abstract

Duchenne muscular dystrophy (DMD) is a severe X-linked neuromuscular disease with an incidence of approximately 1 in 3,500 newborn boys. The DMD locus has a high mutation frequency: one third of the cases is thought to result from a new mutation. Linkage studies using probes to detect restriction fragment length polymorphisms and DNA deletion studies have greatly improved DMD carrier detection and prenatal diagnosis. Here we report on two families in which a pERT87 (DXS164) deletion was transmitted to more than one offspring by women who showed no evidence for the mutation in their own somatic (white blood) cells. We also show that the deletion in both siblings in one of the families is identical, indicating that the deletion must have occurred during mitosis in early germline proliferation, leading to a germline mosaicism. This phenomenon may turn out to be a major factor contributing to the induction of DMD mutations, and has important implications for the counselling of DMD families.

Entities:  

Mesh:

Year:  1987        PMID: 2889144     DOI: 10.1038/329554a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  68 in total

1.  De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10.

Authors:  S M van der Maarel; G Deidda; R J Lemmers; P G van Overveld; M van der Wielen; J E Hewitt; L Sandkuijl; B Bakker; G J van Ommen; G W Padberg; R R Frants
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Genetic analysis of three pedigrees of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS)

Authors:  W Sato; K Hayasaka; K Komatsu; Y Sawaishi; K Sakemi; Y Shoji; G Takada
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

3.  Substitution of aspartate for glycine 1018 in the type III procollagen (COL3A1) gene causes type IV Ehlers-Danlos syndrome: the mutated allele is present in most blood leukocytes of the asymptomatic and mosaic mother.

Authors:  S Kontusaari; G Tromp; H Kuivaniemi; C Stolle; F M Pope; D J Prockop
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

4.  Estimate of germinal mosaicism in Duchenne muscular dystrophy.

Authors:  M R Passos-Bueno; M A Lima; M Zatz
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

5.  Theoretical considerations on germline mosaicism in Duchenne muscular dystrophy.

Authors:  T Grimm; B Müller; C R Müller; M Janka
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

6.  Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations.

Authors:  E Bakker; H Veenema; J T Den Dunnen; C van Broeckhoven; P M Grootscholten; E J Bonten; G J van Ommen; P L Pearson
Journal:  J Med Genet       Date:  1989-09       Impact factor: 6.318

7.  Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene.

Authors:  S Abbs; M Bobrow
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

8.  Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease.

Authors:  E W Murray; A R Giles; D Lillicrap
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

9.  Informative microsatellite markers allow carrier detection in a Duchenne muscular dystrophy deletion pedigree in the absence of DNA from an affected boy.

Authors:  R I Richards; K Friend; E A Haan
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

10.  Germinal "mosaicism"--germline mutation or chimerism?

Authors:  R Witkowski
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.